APA (7th ed.) Citation

E, M., M, B., J, A., CJ, L., F, C., N, K., . . . A, G. (2026). Safety and Immunogenicity of BNT162b2 in Antiretroviral Therapy-Treated People With HIV. Open forum infectious diseases, 13(7), ofag310. https://doi.org/10.1093/ofid/ofag310

Chicago Style (17th ed.) Citation

E, Mitha, et al. "Safety and Immunogenicity of BNT162b2 in Antiretroviral Therapy-Treated People With HIV." Open Forum Infectious Diseases 13, no. 7 (2026): ofag310. https://doi.org/10.1093/ofid/ofag310.

MLA (9th ed.) Citation

E, Mitha, et al. "Safety and Immunogenicity of BNT162b2 in Antiretroviral Therapy-Treated People With HIV." Open Forum Infectious Diseases, vol. 13, no. 7, 2026, p. ofag310, https://doi.org/10.1093/ofid/ofag310.